Sign up to save your podcasts
Or
Share ERJ Podcast March 2025: Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ERJ Podcast March 2025: Generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis.
View all episodes
By ERS Publications Podcasts
4
55 ratings
As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis.
More shows like ERS Publications Podcasts
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
323 Listeners
JAMA Clinical Reviews
499 Listeners
CHEST Journal Podcasts
64 Listeners
Thorax Podcast
1 Listeners
Out of the Blue: An AJRCCM Podcast
37 Listeners
Clinician to Clinician: An AnnalsATS Podcast
13 Listeners
Health Report
129 Listeners
BMJ Best Practice Podcast
19 Listeners
Core IM | Internal Medicine Podcast
1,146 Listeners
Annals On Call Podcast
192 Listeners
JAMA Medical News
93 Listeners
The Intelligence from The Economist
2,552 Listeners
PulmPEEPs
59 Listeners
The Opinions
578 Listeners